4.7 Article

Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

期刊

ALZHEIMERS & DEMENTIA
卷 9, 期 5, 页码 602-608

出版社

WILEY
DOI: 10.1016/j.jalz.2012.12.001

关键词

Neuropsychiatric symptoms; Behavioral and psychological symptoms of dementia; Agitation/aggression; Sleep disorders; Depression; Apathy; Psychosis; Delusions; Hallucinations; Dementia; Alzheimer's disease; Mild cognitive impairment; Mild behavioral impairment

资金

  1. NIMH [K01-MH68351, R24-MH074779, R01-MH079814, RC1-MH090770-01]
  2. NIA [U01-AG006786]
  3. National Center for Research Resources [RR024150]
  4. Robert Wood Johnson Foundation
  5. European Union Regional Development Fund [FNUSA-ICRC: CZ.1.05/1.1.00/02.0123]
  6. Baxter
  7. Elan Pharmaceuticals
  8. Johnson Johnson
  9. Eli Lilly
  10. Myriad
  11. Novartis
  12. Pfizer
  13. Abbott Laboratories
  14. AC Immune
  15. Allergan
  16. Allon
  17. Alzheimer Drug Discovery Foundation
  18. AstraZeneca
  19. Bristol-Myers Squibb
  20. Elan
  21. Exonhit
  22. Forest
  23. GlaxoSmithKline
  24. Ipsen Pharmaceuticals
  25. Lundbeck
  26. Medavante
  27. Medivation
  28. Merck
  29. Merz
  30. Roche
  31. Sanofi-Aventis
  32. Schering-Plough
  33. Schwabe
  34. Toyama
  35. Transition Therapeutics
  36. Alzheimer's Association [IIRG-07-28686]
  37. Johns Hopkins Alzheimer's Disease Research Center [P50-AG005146]
  38. NIMH, MA
  39. Associated Jewish Federation of Baltimore
  40. Weinberg Foundation
  41. Eisai
  42. Lilly
  43. Ortho-McNeil
  44. Bristol-Myers
  45. National Football League
  46. Functional Neuromodulation Inc.

向作者/读者索取更多资源

Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are widespread and disabling. This has been known since Dr. Alois Alzheimer's first case, Frau Auguste D., presented with emotional distress and delusions of infidelity/excessive jealousy, followed by cognitive symptoms. Being cognizant of this, in 2010 the Alzheimer's Association convened a research roundtable on the topic of NPS in AD. A major outcome of the roundtable was the founding of a Professional Interest Area (PIA) within the International Society to Advance Alzheimer's Research and Treatment (ISTAART). The NPS-PIA has prepared a series of documents that are intended to summarize the literature and provide more detailed specific recommendations for NPS research. This overview paper is the first of these living documents that will be updated periodically as the science advances. The overview is followed by syndrome-specific synthetic reviews and recommendations prepared by NPS-PIA workgroups on depression, apathy, sleep, agitation, and psychosis. (C) 2013 The Alzheimer's Association. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据